|
|
12040 115th Ave., NE
Kirkland, WA 98034 USA
phone:(425) 823-0400
fax:
|
|
| Symbol |
Private |
| Founded |
1996 |
| Employees |
|
|
|
| www.proteotech.com
|
|
|
|
 |
| Summary Description |
| Drug development Company targeting amyloid diseases. |
|
| Management |
| Alan D. Snow, Chairman, President, and Chief Scientific Officer; Steve Runnels, Chief Executive Officer; Dennis McCurley, Chief Operations Officer and Chief Financial Office; William T. Frantz
|
| |
|
|
| |
|
| Keywords |
| Systemic amyloidosis, Exebryl-1, Synuclere, Systebryl, PeptiClere, Alzheimer's Disease.
|
|
|
|
| Description |
|
ProteoTech Inc. is a private drug development Company founded in 1996 that is located in the Seattle, WA area (Kirkland, WA), and is focused on targeting amyloid diseases. ProteoTech is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of Alzheimer's disease, Parkinson's disease, type 2 diabetes and systemic amyloidosis. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members